AMANDA TRAN: Open Payments
NPI 1437899572 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 16 payments from 7 companies in 2025. Trend: 2023 $1,124 · 2024 $1,517 · 2025 $563
Food & beverage: $544Education: $19
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 3 | $181 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $179 |
| Tandem Diabetes Care, Inc. | 1 | $84 |
| Lilly USA, LLC | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Ascendis Pharma Endocrinology Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
Products named: TWIIST, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, GVOKE HYPOPEN, Yorvipath, Dexcom G6 Transmitter.
Industry payments across MI — which companies pay providers there.
